drugset / Trial / NCT01691560

Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

NCT01691560 ↗

Phase 2 Completed 140 enrolled GlaxoSmithKline BioSci Research · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this exploratory study is to compare the treatment effect on dentinal hypersensitivity of a tubule occluding dentifrice as measured by Schiff and Tactile sensitivity. This proof of concept study will compare the test dentifrice with three other treatment groups.

Timeline

Start
2012-08
Primary completion
2012-11
Completion
2012-11

Outcome

Mixed primary results

registry analysis (superiority or other test); 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate vs 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate; p = 0.4553 NCT01691560 ↗

registry MEAN 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate: 7.31 (Standard Deviation 11.227) grams NCT01691560 ↗

registry MEAN 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate: 3.64 (Standard Deviation 6.030) grams NCT01691560 ↗

registry analysis (superiority or other test); 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate vs 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate; p = 0.0467; Median Difference (Final Values) 0 (95% CI 0 to 5); Wilcoxon (Mann-Whitney) NCT01691560 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject PHOSPHINE SILANE Other / unclassified 5 % —
Comparator sodium fluoride Unknown 1100 ppm —
Comparator sodium monofluorophosphate Unknown 1000 ppm —
Comparator sodium monofluorophosphate Unknown 1500 ppm —

Indications